Innovative AI Tool Enhances Heart Disease Detection Using Standard ECG Data
A cutting-edge AI tool analyzes routine ECG data to detect hidden structural heart diseases, promising earlier diagnosis and treatment opportunities. Developed by Columbia University researchers, EchoNext offers a cost-effective, non-invasive method to identify patients needing further cardiac evaluation, potentially saving countless lives.
Recent advancements in artificial intelligence (AI) have led to the development of a novel, cost-effective screening tool capable of identifying hidden structural heart diseases from routine electrocardiogram (ECG) data. Traditionally, ECGs are employed to detect abnormal heart rhythms, blockages, and previous heart attacks, but they have limitations in diagnosing structural issues such as valve disease and cardiomyopathy. To bridge this gap, researchers at Columbia University Irving Medical Center and NewYork-Presbyterian created EchoNext, an AI-powered system that analyzes standard ECG readings to determine which patients should proceed with an echocardiogram—a more detailed, ultrasound-based heart imaging test.
The AI model was trained on over 1.2 million paired ECG and echocardiogram data from 230,000 patients, enabling it to spot signs of structural heart problems more accurately than many cardiologists, even with AI assistance. In a validation study across four hospital systems, including several NewYork-Presbyterian campuses, EchoNext demonstrated high accuracy in detecting conditions like heart failure, valve disease, pulmonary hypertension, and significant heart thickening. When compared directly with 13 cardiologists analyzing 3,200 ECGs, EchoNext correctly identified 77% of structural heart diseases, outperforming human experts with a 64% accuracy rate.
In real-world applications, the AI system screened nearly 85,000 patients who had not previously undergone echocardiography. It flagged over 7,500 individuals as high-risk, and during follow-up, about 55% of these patients subsequently received their first echocardiogram, leading to a diagnosis of structural heart disease in nearly three-quarters of them. This approach has the potential to significantly increase early detection, potentially saving many lives by enabling timely treatment. The team has also shared anonymized data to support further research and is conducting clinical trials to implement EchoNext in emergency settings. Overall, this innovation exemplifies how AI can transform cardiac screening, making it more accessible and effective worldwide.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How Minute Cellular Interactions Help Cancer Spread and Potential Therapeutic Opportunities
Recent research uncovers how subtle cellular signaling interactions may contribute to cancer metastasis, opening new avenues for targeted therapies that inhibit tumor spread without impairing immune responses.
Revolutionary Insights: Changes in Internal Fat Biology as a Key Driver of Heart Failure
New research reveals that changes in the biology of internal fat tissue may be the key cause of heart failure with preserved ejection fraction (HFpEF), opening new avenues for targeted treatments.
Experts Call for Distinct Roles for AI and Radiologists to Optimize Imaging Diagnostics
Leading experts emphasize the importance of defining distinct roles for AI systems and radiologists to enhance diagnostic workflows and patient care. A strategic separation fosters trust, efficiency, and innovation in medical imaging.
Dietary Cysteine May Boost Intestinal Regeneration and Repair
Discover how a cysteine-rich diet may promote regeneration of the intestinal lining, helping to heal injuries from radiation and chemotherapy. Research from MIT highlights the potential of natural amino acids in tissue repair.